Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 16.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 150.00
  • 52 Week Low: 15.25
  • Currency: UK Pounds
  • Shares Issued: 97.43m
  • Volume: 2,521
  • Market Cap: £15.59m
  • RiskGrade: 348
  • Beta: 0.71

RENX Overview

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1244.6% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 5.7 n/a
Pr/Book 1.1  
Latest F'cast
Revenue 14.6% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

RENX Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 n/a (7.12) (17.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-20 n/a (10.61) (16.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-21 1.49 (35.79) (43.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-22 2.97 (49.63) (78.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-23 3.40 (46.22) (56.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

RENX Company Announcements

Directorate Change 08-Dec-2023 18:14 RNS
Grant of Share Options 23-Nov-2023 07:00 RNS
Publication of Annual Report 2023 & Notice of AGM 17-Nov-2023 15:56 RNS

RENX ShareCast News

Renalytix kidney test claims allowed by US Paten... 06-Oct-2023 ShareCast
Renalytix gets KidneyIntelX included in major cl... 21-Aug-2023 ShareCast
Renalytix launches kidney disease test in Arabia... 21-Jul-2023 ShareCast

Latest RENX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

RENX Market Data

Currency UK Pounds
Share Price 16.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 150.00
52 Week Low 15.25
Volume 2,521
Shares Issued 97.43m
Market Cap £15.59m
Beta 0.71
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
16.68% above the market average16.68% above the market average16.68% above the market average16.68% above the market average16.68% above the market average
56.25% above the sector average56.25% above the sector average56.25% above the sector average56.25% above the sector average56.25% above the sector average
Price Trend
98.99% below the market average98.99% below the market average98.99% below the market average98.99% below the market average98.99% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
13.02% above the market average13.02% above the market average13.02% above the market average13.02% above the market average13.02% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

RENX Dividends

No dividends found

Trades for 08-Dec-2023

Time Volume / Share Price
15:50 747 @ 15.25p
15:46 2 @ 15.55p
14:02 1,509 @ 16.56p
13:48 263 @ 15.50p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page